| 泪腺腺样囊性癌生物标志物的研究进展 |
| |
| 引用本文： | 李田,董志军.泪腺腺样囊性癌生物标志物的研究进展[J].国际眼科杂志,2021,21(8):1404-1407. |
| |
| 作者姓名： | 李田 董志军 |
| |
| 作者单位： | 中国河北省承德市,承德医学院附属医院眼科,中国河北省承德市,承德医学院附属医院眼科 |
| |
| 基金项目： | 河北省医学科学研究课题计划项目(No.20200366) |
| |
| 摘 要： | 泪腺腺样囊性癌是泪腺最常见的恶性上皮肿瘤，具有易复发、易转移及预后差的特点，目前临床治疗方式主要有手术切除、放疗、化疗等，但其生存率仍低。因此，进一步研究泪腺腺样囊性癌的发病机制和寻找泪腺腺样囊性癌的生物标志物尤为迫切。本文将对泪腺腺样囊性癌的生物标志物的研究进展作一综述。
|
| 关 键 词： | 泪腺腺样囊性癌 生物标志物 进展 机制 增殖 |
| 收稿时间： | 2020/10/30 0:00:00 |
| 修稿时间： | 2021/6/30 0:00:00 |
Research progress of biomarkers in adenoid cystic carcinoma of lacrimal gland |
| |
| Tian Li and Zhi-Jun Dong.Research progress of biomarkers in adenoid cystic carcinoma of lacrimal gland[J].International Journal of Ophthalmology,2021,21(8):1404-1407. |
| |
| Authors: | Tian Li and Zhi-Jun Dong |
| |
| Institution: | Department of Ophthalmology, Affiliated Hospital of Chengde Medical College, Chengde 067000, Hebei Province, China and Department of Ophthalmology, Affiliated Hospital of Chengde Medical College, Chengde 067000, Hebei Province, China |
| |
| Abstract: | Adenoid cystic carcinoma of lacrimal gland(LGACC)is the most common malignant epithelial tumor of the lacrimal gland, which is characterized by high recurrence rate, easy metastasis and poor prognosis. Although the current clinical treatment modalities for adenoid cystic carcinoma of lacrimal gland mainly include surgical resection, radiotherapy, and chemotherapy, its survival rate is still low. Therefore, it is particularly urgent to further study the pathogenesis of adenoid cystic carcinoma of the lacrimal gland and find out the biomarkers for adenoid cystic carcinoma of the lacrimal gland. In this paper, we will review the research progress in biomarkers of adenoid cystic carcinoma of the lacrimal gland. |
| |
| Keywords: | adenoid cystic carcinoma of lacrimal gland biomarkers progress mechanism proliferation |
|
| 点击此处可从《国际眼科杂志》浏览原始摘要信息 |
| 点击此处可从《国际眼科杂志》下载免费的PDF全文 |
|
